Petrus Adrianus Frederik Maria Doevendans - Publications

Affiliations: 
2004- Utrecht University, Utrecht, Netherlands 
Area:
Cardiac electrophysiology
Website:
https://profs.library.uu.nl/index.php/profrec/getprofdata/509/1/2/0

115 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Bracco Gartner TCL, Stein JM, Muylaert DEP, Bouten CVC, Doevendans PA, Khademhosseini A, Suyker WJL, Sluijter JPG, Hjortnaes J. Advanced Modeling to Study the Paradox of Mechanically Induced Cardiac Fibrosis. Tissue Engineering. Part C, Methods. 27: 100-114. PMID 33407000 DOI: 10.1089/ten.TEC.2020.0298  0.356
2020 Kamphuis JAM, Linschoten M, Cramer MJ, Doevendans PA, Asselbergs FW, Teske AJ. Early- and late anthracycline-induced cardiac dysfunction: echocardiographic characterization and response to heart failure therapy. Cardio-Oncology (London, England). 6: 23. PMID 33072403 DOI: 10.1186/s40959-020-00079-3  0.304
2020 Buikema JW, Lee S, Goodyer WR, Maas RG, Chirikian O, Li G, Miao Y, Paige SL, Lee D, Wu H, Paik DT, Rhee S, Tian L, Galdos FX, Puluca N, ... ... Doevendans PA, et al. Wnt Activation and Reduced Cell-Cell Contact Synergistically Induce Massive Expansion of Functional Human iPSC-Derived Cardiomyocytes. Cell Stem Cell. 27: 50-63.e5. PMID 32619518 DOI: 10.1016/J.Stem.2020.06.001  0.306
2019 van den Hoogen P, de Jager SCA, Mol EA, Schoneveld AS, Huibers MMH, Vink A, Doevendans PA, Laman JD, Sluijter JPG. Potential of mesenchymal- and cardiac progenitor cells for therapeutic targeting of B-cells and antibody responses in end-stage heart failure. Plos One. 14: e0227283. PMID 31891633 DOI: 10.1371/journal.pone.0227283  0.439
2019 Bracco Gartner TCL, Deddens JC, Mol EA, Magin Ferrer M, van Laake LW, Bouten CVC, Khademhosseini A, Doevendans PA, Suyker WJL, Sluijter JPG, Hjortnaes J. Anti-fibrotic Effects of Cardiac Progenitor Cells in a 3D-Model of Human Cardiac Fibrosis. Frontiers in Cardiovascular Medicine. 6: 52. PMID 31080805 DOI: 10.3389/Fcvm.2019.00052  0.405
2018 van Mil A, Balk GM, Neef K, Buikema JW, Asselbergs FW, Wu SM, Doevendans PA, Sluijter JP. Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls and potential. Cardiovascular Research. PMID 30169602 DOI: 10.1093/cvr/cvy208  0.451
2018 van den Akker F, Vrijsen KR, Deddens JC, Buikema JW, Mokry M, van Laake LW, Doevendans PA, Sluijter JPG. Suppression of T cells by mesenchymal and cardiac progenitor cells is partly mediated via extracellular vesicles. Heliyon. 4: e00642. PMID 30003150 DOI: 10.1016/j.heliyon.2018.e00642  0.418
2018 Gathier WA, van Ginkel DJ, van der Naald M, van Slochteren FJ, Doevendans PA, Chamuleau SAJ. Retrograde Coronary Venous Infusion as a Delivery Strategy in Regenerative Cardiac Therapy: an Overview of Preclinical and Clinical Data. Journal of Cardiovascular Translational Research. 11: 173-181. PMID 29392536 DOI: 10.1007/s12265-018-9785-1  0.314
2018 Gathier WA, Van Der Naald M, Van Klarenbosch BR, Tuinenburg AE, Bemelmans J, Sluijter J, Van Slochteren FJ, Doevendans PA, Chamuleau S. P111Retention of mesenchymal stem cells in the heart is lower after retrograde coronary venous infusion compared to intracoronary infusion in a porcine model of chronic myocardial infarction Cardiovascular Research. 114: S29-S29. DOI: 10.1093/CVR/CVY060.074  0.373
2017 Du Pré BC, Demkes EJ, Feyen DAM, Dierickx P, Crnko S, Kok BJM, Sluijter JPG, Doevendans PA, Vos MA, Van Veen TAB, Van Laake LW. SCA1(+) Cells from the Heart Possess a Molecular Circadian Clock and Display Circadian Oscillations in Cellular Functions. Stem Cell Reports. PMID 28803917 DOI: 10.1016/j.stemcr.2017.07.010  0.309
2017 Dierickx P, Vermunt MW, Muraro MJ, Creyghton MP, Doevendans PA, van Oudenaarden A, Geijsen N, Van Laake LW. Circadian networks in human embryonic stem cell-derived cardiomyocytes. Embo Reports. PMID 28536247 DOI: 10.15252/embr.201743897  0.393
2017 Deddens JC, Feyen DA, Zwetsloot PP, Brans MA, Siddiqi S, van Laake LW, Doevendans PA, Sluijter JP. Targeting chronic cardiac remodeling with cardiac progenitor cells in a murine model of ischemia/reperfusion injury. Plos One. 12: e0173657. PMID 28319168 DOI: 10.1371/journal.pone.0173657  0.355
2016 Vrijsen KR, Maring JA, Chamuleau SA, Verhage V, Mol EA, Deddens JC, Metz CH, Lodder K, van Eeuwijk EC, van Dommelen SM, Doevendans PA, Smits AM, Goumans MJ, Sluijter JP. Exosomes from Cardiomyocyte Progenitor Cells and Mesenchymal Stem Cells Stimulate Angiogenesis Via EMMPRIN. Advanced Healthcare Materials. 5: 2555-2565. PMID 27570124 DOI: 10.1002/adhm.201600308  0.399
2016 Feyen DAM, Gaetani R, Doevendans PA, Sluijter JPG. Stem cell-based therapy: Improving myocardial cell delivery. Advanced Drug Delivery Reviews. 106: 104-115. PMID 27133386 DOI: 10.1016/j.addr.2016.04.023  0.396
2016 Feyen DA, Gaetani R, Deddens J, van Keulen D, van Opbergen C, Poldervaart M, Alblas J, Chamuleau S, van Laake LW, Doevendans PA, Sluijter JP. Gelatin Microspheres as Vehicle for Cardiac Progenitor Cells Delivery to the Myocardium. Advanced Healthcare Materials. 5: 1071-9. PMID 26913710 DOI: 10.1002/adhm.201500861  0.458
2016 Zwetsloot PP, Végh AM, Jansen Of Lorkeers SJ, van Hout GP, Currie GL, Sena ES, Gremmels H, Buikema JW, Goumans MJ, Macleod MR, Doevendans PA, Chamuleau SA, Sluijter JP. Cardiac Stem Cell Treatment in Myocardial Infarction: A Systematic Review and Meta-Analysis of Preclinical Studies. Circulation Research. PMID 26888636 DOI: 10.1161/CIRCRESAHA.115.307676  0.399
2016 Feyen DAM, Gaetani R, Deddens J, van Keulen D, van Opbergen C, Poldervaart M, Alblas J, Chamuleau S, van Laake LW, Doevendans PA, Sluijter JPG. Gelatin Microspheres as Vehicle for Cardiac Progenitor Cells Delivery to the Myocardium Advanced Healthcare Materials. 5: 1071-1079. DOI: 10.1002/adhm.201500861  0.459
2015 Jansen Of Lorkeers SJ, Gho JM, Koudstaal S, van Hout GP, Zwetsloot PP, van Oorschot JW, van Eeuwijk EC, Leiner T, Hoefer IE, Goumans MJ, Doevendans PA, Sluijter JP, Chamuleau SA. Xenotransplantation of Human Cardiomyocyte Progenitor Cells Does Not Improve Cardiac Function in a Porcine Model of Chronic Ischemic Heart Failure. Results from a Randomized, Blinded, Placebo Controlled Trial. Plos One. 10: e0143953. PMID 26678993 DOI: 10.1371/journal.pone.0143953  0.422
2015 Gaetani R, Yin C, Srikumar N, Braden R, Doevendans PA, Sluijter JP, Christman KL. Cardiac derived extracellular matrix enhances cardiogenic properties of human cardiac progenitor cells. Cell Transplantation. PMID 26572770 DOI: 10.3727/096368915X689794  0.379
2015 Schüssler-Lenz M, Beuneu C, Menezes-Ferreira M, Jekerle V, Bartunek J, Chamuleau S, Celis P, Doevendans P, O'Donovan M, Hill J, Hystad M, Jovinge S, Kyselovič J, Lipnik-Stangelj M, Maciulaitis R, et al. Cell-based therapies for cardiac repair: a meeting report on scientific observations and European regulatory viewpoints. European Journal of Heart Failure. PMID 26470631 DOI: 10.1002/ejhf.422  0.397
2015 van der Spoel TI, Gathier WA, Koudstaal S, van Slochteren F, Of Lorkeers SJ, Sluijter JP, Hoefer IE, Steendijk P, Cramer MJ, Doevendans PA, van Belle E, Chamuleau SA. Autologous Mesenchymal Stem Cells Show More Benefit on Systolic Function Compared to Bone Marrow Mononuclear Cells in a Porcine Model of Chronic Myocardial Infarction. Journal of Cardiovascular Translational Research. 8: 393-403. PMID 26382088 DOI: 10.1007/s12265-015-9643-3  0.379
2015 Gaetani R, Feyen DA, Verhage V, Slaats R, Messina E, Christman KL, Giacomello A, Doevendans PA, Sluijter JP. Epicardial application of cardiac progenitor cells in a 3D-printed gelatin/hyaluronic acid patch preserves cardiac function after myocardial infarction. Biomaterials. 61: 339-48. PMID 26043062 DOI: 10.1016/J.Biomaterials.2015.05.005  0.441
2015 Jansen Of Lorkeers SJ, Eding JE, Vesterinen HM, van der Spoel TI, Sena ES, Duckers HJ, Doevendans PA, Macleod MR, Chamuleau SA. Similar effect of autologous and allogeneic cell therapy for ischemic heart disease: systematic review and meta-analysis of large animal studies. Circulation Research. 116: 80-6. PMID 25186794 DOI: 10.1161/CIRCRESAHA.116.304872  0.411
2014 Gaetani R, Feyen DA, Doevendans PA, Gremmels H, Forte E, Fledderus JO, Ramjankhan FZ, Messina E, Sussman MA, Giacomello A, Sluijter JP. Different types of cultured human adult cardiac progenitor cells have a high degree of transcriptome similarity. Journal of Cellular and Molecular Medicine. 18: 2147-51. PMID 25311343 DOI: 10.1111/Jcmm.12458  0.423
2014 Jansen Of Lorkeers SJ, Hart E, Tang XL, Chamuleau ME, Doevendans PA, Bolli R, Chamuleau SA. Cyclosporin in cell therapy for cardiac regeneration. Journal of Cardiovascular Translational Research. 7: 475-82. PMID 24831573 DOI: 10.1007/s12265-014-9570-8  0.449
2014 Sluijter JPG, Verhage V, Deddens JC, Van Den Akker F, Doevendans PA. Microvesicles and exosomes for intracardiac communication Cardiovascular Research. 102: 302-311. PMID 24488559 DOI: 10.1093/cvr/cvu022  0.369
2014 Koudstaal S, Bastings MMC, Feyen DAM, Waring CD, Van Slochteren FJ, Dankers PYW, Torella D, Sluijter JPG, Nadal-Ginard B, Doevendans PA, Ellison GM, Chamuleau SAJ. Sustained delivery of insulin-like growth factor-1/hepatocyte growth factor stimulates endogenous cardiac repair in the chronic infarcted pig heart Journal of Cardiovascular Translational Research. 7: 232-241. PMID 24395494 DOI: 10.1007/s12265-013-9518-4  0.329
2014 Jansen of Lorkeers S, Eding J, Van der Spoel T, Vesterinen H, Sena E, Doevendans P, Macleod M, Chamuleau S. SIMILAR EFFECT OF AUTOLOGOUS AND ALLOGENEIC CELL THERAPY FOR ISCHEMIC HEART DISEASE: RESULTS FROM A META-ANALYSIS OF LARGE ANIMAL STUDIES Journal of the American College of Cardiology. 63: A1762. DOI: 10.1016/S0735-1097(14)61765-4  0.302
2013 Buikema JW, Zwetsloot PP, Doevendans PA, Sluijter JP, Domian IJ. Expanding mouse ventricular cardiomyocytes through GSK-3 inhibition. Current Protocols in Cell Biology. 61: 23.9.1-23.9.10. PMID 24505027 DOI: 10.1002/0471143030.cb2309s61  0.335
2013 Buikema JW, Mady AS, Mittal NV, Atmanli A, Caron L, Doevendans PA, Sluijter JPG, Domian IJ. Wnt/β-catenin signaling directs the regional expansion of first and second heart field-derived ventricular cardiomyocytes Development (Cambridge). 140: 4165-4176. PMID 24026118 DOI: 10.1242/dev.099325  0.431
2013 du Pré BC, Doevendans PA, van Laake LW. Stem cells for cardiac repair: an introduction. Journal of Geriatric Cardiology : Jgc. 10: 186-97. PMID 23888179 DOI: 10.3969/j.issn.1671-5411.2013.02.003  0.523
2013 Gho JM, Kummeling GJ, Koudstaal S, Jansen Of Lorkeers SJ, Doevendans PA, Asselbergs FW, Chamuleau SA. Cell therapy, a novel remedy for dilated cardiomyopathy? A systematic review. Journal of Cardiac Failure. 19: 494-502. PMID 23834925 DOI: 10.1016/j.cardfail.2013.05.006  0.364
2013 Koudstaal S, Jansen Of Lorkeers SJ, Gaetani R, Gho JMIHG, Van Slochteren FJ, Sluijter JPG, Doevendans PA, Ellison GM, Chamuleau SAJ. Concise review: Heart regeneration and the role of cardiac stem cells Stem Cells Translational Medicine. 2: 434-443. PMID 23658251 DOI: 10.5966/sctm.2013-0001  0.48
2013 van Mil A, Vrijsen KR, Goumans MJ, Metz CH, Doevendans PA, Sluijter JP. MicroRNA-1 enhances the angiogenic differentiation of human cardiomyocyte progenitor cells. Journal of Molecular Medicine (Berlin, Germany). 91: 1001-12. PMID 23625462 DOI: 10.1007/s00109-013-1017-1  0.354
2013 Feyen D, Gaetani R, Liu J, Noort W, Martens A, den Ouden K, Doevendans PA, Sluijter JP. Increasing short-term cardiomyocyte progenitor cell (CMPC) survival by necrostatin-1 did not further preserve cardiac function. Cardiovascular Research. 99: 83-91. PMID 23554461 DOI: 10.1093/cvr/cvt078  0.444
2013 Van Den Akker F, Deddens JC, Doevendans PA, Sluijter JPG. Cardiac stem cell therapy to modulate inflammation upon myocardial infarction Biochimica Et Biophysica Acta - General Subjects. 1830: 2449-2458. PMID 22975401 DOI: 10.1016/j.bbagen.2012.08.026  0.424
2013 Oerlemans MI, Koudstaal S, Chamuleau SA, de Kleijn DP, Doevendans PA, Sluijter JP. Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection. International Journal of Cardiology. 165: 410-22. PMID 22459400 DOI: 10.1016/j.ijcard.2012.03.055  0.303
2013 Jansen Of Lorkeers SJ, Eding JEC, Van Der Spoel TIG, Vesterinen HM, Koudstaal S, Sena ES, Doevendans PA, Macleod MR, Chamuleau SAJ. Similar effect of autologous and allogeneic cell therapy for ischemic heart disease: results from a meta-analysis of large animal studies European Heart Journal. 34: P1462-P1462. DOI: 10.1093/EURHEARTJ/EHT308.P1462  0.302
2013 Van Den Akker F, Vrijsen KR, Deddens JC, Doevendans PA, Sluijter JPG. Progenitor cells suppress t-cell proliferation via a paracrine mechanism European Heart Journal. 34: P1456-P1456. DOI: 10.1093/EURHEARTJ/EHT308.P1456  0.319
2012 Dierickx P, Doevendans PA, Geijsen N, van Laake LW. Embryonic template-based generation and purification of pluripotent stem cell-derived cardiomyocytes for heart repair. Journal of Cardiovascular Translational Research. 5: 566-80. PMID 22806916 DOI: 10.1007/s12265-012-9391-6  0.523
2012 van Vliet P, Goumans MJ, Doevendans PA, Sluijter JP. Human cardiomyocyte progenitor cells: a short history of nearly everything. Journal of Cellular and Molecular Medicine. 16: 1669-73. PMID 22260290 DOI: 10.1111/j.1582-4934.2012.01535.x  0.784
2012 Gaetani R, Doevendans PA, Metz CH, Alblas J, Messina E, Giacomello A, Sluijter JP. Cardiac tissue engineering using tissue printing technology and human cardiac progenitor cells. Biomaterials. 33: 1782-90. PMID 22136718 DOI: 10.1016/j.biomaterials.2011.11.003  0.435
2012 Mercola M, Doevendans P. Meeting review: cardiomyocyte regeneration and protection, La Jolla, California, June 2011. Journal of Cardiovascular Translational Research. 5: 100-5. PMID 22057688 DOI: 10.1007/S12265-011-9323-X  0.423
2012 den Haan MC, Grauss RW, Smits AM, Winter EM, van Tuyn J, Pijnappels DA, Steendijk P, Gittenberger-De Groot AC, van der Laarse A, Fibbe WE, de Vries AA, Schalij MJ, Doevendans PA, Goumans MJ, Atsma DE. Cardiomyogenic differentiation-independent improvement of cardiac function by human cardiomyocyte progenitor cell injection in ischaemic mouse hearts. Journal of Cellular and Molecular Medicine. 16: 1508-21. PMID 22003890 DOI: 10.1111/j.1582-4934.2011.01468.x  0.366
2012 Noort WA, Oerlemans MI, Rozemuller H, Feyen D, Jaksani S, Stecher D, Naaijkens B, Martens AC, Bühring HJ, Doevendans PA, Sluijter JP. Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation. Journal of Cellular and Molecular Medicine. 16: 1827-39. PMID 21973026 DOI: 10.1111/j.1582-4934.2011.01455.x  0.384
2011 Sluijter JP, Doevendans PA, Goumans MJ. Letter by Sluijter et al regarding article, "Human cardiac stem cell differentiation is regulated by a mircrine mechanism". Circulation. 124: e456; author's reply. PMID 22025645 DOI: 10.1161/CIRCULATIONAHA.111.037655  0.353
2011 van der Spoel TI, Jansen of Lorkeers SJ, Agostoni P, van Belle E, Gyöngyösi M, Sluijter JP, Cramer MJ, Doevendans PA, Chamuleau SA. Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease. Cardiovascular Research. 91: 649-58. PMID 21498423 DOI: 10.1093/cvr/cvr113  0.34
2011 Timmers L, Lim SK, Hoefer IE, Arslan F, Lai RC, van Oorschot AA, Goumans MJ, Strijder C, Sze SK, Choo A, Piek JJ, Doevendans PA, Pasterkamp G, de Kleijn DP. Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Research. 6: 206-14. PMID 21419744 DOI: 10.1016/J.Scr.2011.01.001  0.384
2011 Arslan F, Smeets MB, Riem Vis PW, Karper JC, Quax PH, Bongartz LG, Peters JH, Hoefer IE, Doevendans PA, Pasterkamp G, de Kleijn DP. Lack of fibronectin-EDA promotes survival and prevents adverse remodeling and heart function deterioration after myocardial infarction. Circulation Research. 108: 582-92. PMID 21350212 DOI: 10.1161/Circresaha.110.224428  0.304
2011 van Oorschot AA, Smits AM, Pardali E, Doevendans PA, Goumans MJ. Low oxygen tension positively influences cardiomyocyte progenitor cell function. Journal of Cellular and Molecular Medicine. 15: 2723-34. PMID 21306557 DOI: 10.1111/j.1582-4934.2011.01270.x  0.403
2011 van der Spoel TI, Lee JC, Vrijsen K, Sluijter JP, Cramer MJ, Doevendans PA, van Belle E, Chamuleau SA. Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardium. The International Journal of Cardiovascular Imaging. 27: 367-83. PMID 20577813 DOI: 10.1007/s10554-010-9658-4  0.4
2011 van der Laan A, Hirsch A, Nijveldt R, van der Vleuten PA, van der Giessen WJ, Doevendans PA, Waltenberger J, Ten Berg JM, Aengevaeren WR, Zwaginga JJ, Biemond BJ, van Rossum AC, Tijssen JG, Zijlstra F, Piek JJ. Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results. Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation. 16: 436-9. PMID 19127324 DOI: 10.1007/BF03086194  0.304
2011 Doevendans PA, van Belle E. The difference between ballistocardiography and stem cells. Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation. 16: 291-2. PMID 18827871 DOI: 10.1007/BF03086166  0.372
2010 Post S, Goumans MJ, Doevendans PA. Peripheral blood derived cell trafficking for cardiac regeneration. Current Stem Cell Research & Therapy. 5: 303-13. PMID 20528755 DOI: 10.2174/157488810793351712  0.448
2010 Vrijsen KR, Sluijter JP, Schuchardt MW, van Balkom BW, Noort WA, Chamuleau SA, Doevendans PA. Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells. Journal of Cellular and Molecular Medicine. 14: 1064-70. PMID 20465578 DOI: 10.1111/j.1582-4934.2010.01081.x  0.462
2010 Oerlemans MI, Goumans MJ, van Middelaar B, Clevers H, Doevendans PA, Sluijter JP. Active Wnt signaling in response to cardiac injury. Basic Research in Cardiology. 105: 631-41. PMID 20373104 DOI: 10.1007/S00395-010-0100-9  0.327
2010 van Vliet P, de Boer TP, van der Heyden MA, El Tamer MK, Sluijter JP, Doevendans PA, Goumans MJ. Hyperpolarization induces differentiation in human cardiomyocyte progenitor cells. Stem Cell Reviews. 6: 178-85. PMID 20354915 DOI: 10.1007/s12015-010-9142-5  0.781
2010 van Vliet P, Smits AM, de Boer TP, Korfage TH, Metz CH, Roccio M, van der Heyden MA, van Veen TA, Sluijter JP, Doevendans PA, Goumans MJ. Foetal and adult cardiomyocyte progenitor cells have different developmental potential. Journal of Cellular and Molecular Medicine. 14: 861-70. PMID 20219011 DOI: 10.1111/j.1582-4934.2010.01053.x  0.762
2010 Sluijter JP, van Mil A, van Vliet P, Metz CH, Liu J, Doevendans PA, Goumans MJ. MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 859-68. PMID 20081117 DOI: 10.1161/ATVBAHA.109.197434  0.754
2010 van Laake LW, van Donselaar EG, Monshouwer-Kloots J, Schreurs C, Passier R, Humbel BM, Doevendans PA, Sonnenberg A, Verkleij AJ, Mummery CL. Extracellular matrix formation after transplantation of human embryonic stem cell-derived cardiomyocytes. Cellular and Molecular Life Sciences : Cmls. 67: 277-90. PMID 19844658 DOI: 10.1007/s00018-009-0179-z  0.379
2010 de Boer TP, van Veen TA, Jonsson MK, Kok BG, Metz CH, Sluijter JP, Doevendans PA, de Bakker JM, Goumans MJ, van der Heyden MA. Human cardiomyocyte progenitor cell-derived cardiomyocytes display a maturated electrical phenotype. Journal of Molecular and Cellular Cardiology. 48: 254-60. PMID 19460390 DOI: 10.1016/j.yjmcc.2009.05.004  0.433
2009 Winter EM, van Oorschot AA, Hogers B, van der Graaf LM, Doevendans PA, Poelmann RE, Atsma DE, Gittenberger-de Groot AC, Goumans MJ. A new direction for cardiac regeneration therapy: application of synergistically acting epicardium-derived cells and cardiomyocyte progenitor cells. Circulation. Heart Failure. 2: 643-53. PMID 19919990 DOI: 10.1161/CIRCHEARTFAILURE.108.843722  0.5
2009 Palmen M, Twickler MT, Daemen MJ, Cramer MJ, Doevendans PA. The role of insulin-like growth factor during a postischemic period - new insights into pathophysiologic pathways in cardiac tissue. Future Cardiology. 1: 479-88. PMID 19804148 DOI: 10.2217/14796678.1.4.479  0.32
2009 van Laake LW, Passier R, den Ouden K, Schreurs C, Monshouwer-Kloots J, Ward-van Oostwaard D, van Echteld CJ, Doevendans PA, Mummery CL. Improvement of mouse cardiac function by hESC-derived cardiomyocytes correlates with vascularity but not graft size. Stem Cell Research. 3: 106-12. PMID 19560991 DOI: 10.1016/j.scr.2009.05.004  0.312
2009 Smits AM, van Laake LW, den Ouden K, Schreurs C, Szuhai K, van Echteld CJ, Mummery CL, Doevendans PA, Goumans MJ. Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovascular Research. 83: 527-35. PMID 19429921 DOI: 10.1093/cvr/cvp146  0.481
2009 Smits AM, van den Hengel LG, van den Brink S, Metz CH, Doevendans PA, Goumans MJ. A new in vitro model for stem cell differentiation and interaction. Stem Cell Research. 2: 108-12. PMID 19383416 DOI: 10.1016/j.scr.2008.10.002  0.373
2009 Chamuleau SA, van Belle E, Doevendans PA. Enhancing cardiac stem cell differentiation into cardiomyocytes. Cardiovascular Research. 82: 385-7. PMID 19357138 DOI: 10.1093/cvr/cvp114  0.483
2009 Liu J, Sluijter JP, Goumans MJ, Smits AM, van der Spoel T, Nathoe H, Doevendans PA. Cell therapy for myocardial regeneration. Current Molecular Medicine. 9: 287-98. PMID 19355911 DOI: 10.2174/156652409787847218  0.45
2009 Smits AM, van Vliet P, Metz CH, Korfage T, Sluijter JP, Doevendans PA, Goumans MJ. Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology. Nature Protocols. 4: 232-43. PMID 19197267 DOI: 10.1038/nprot.2008.229  0.78
2009 Noort WA, Sluijter JP, Goumans MJ, Chamuleau SA, Doevendans PA. Stem cells from in- or outside of the heart: isolation, characterization, and potential for myocardial tissue regeneration. Pediatric Cardiology. 30: 699-709. PMID 19184178 DOI: 10.1007/s00246-008-9370-5  0.452
2008 Bot PT, Hoefer IE, Sluijter JP, van Vliet P, Smits AM, Lebrin F, Moll F, de Vries JP, Doevendans P, Piek JJ, Pasterkamp G, Goumans MJ. Increased expression of the transforming growth factor-beta signaling pathway, endoglin, and early growth response-1 in stable plaques. Stroke. 40: 439-47. PMID 19074480 DOI: 10.1161/Strokeaha.108.522284  0.669
2008 van Vliet P, Roccio M, Smits AM, van Oorschot AA, Metz CH, van Veen TA, Sluijter JP, Doevendans PA, Goumans MJ. Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy. Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation. 16: 163-9. PMID 18566670 DOI: 10.1007/BF03086138  0.787
2008 van Laake LW, Passier R, Doevendans PA, Mummery CL. Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circulation Research. 102: 1008-10. PMID 18436793 DOI: 10.1161/CIRCRESAHA.108.175505  0.421
2008 Roccio M, Goumans MJ, Sluijter JP, Doevendans PA. Stem cell sources for cardiac regeneration. Panminerva Medica. 50: 19-30. PMID 18427385  0.53
2008 Hassink RJ, Pasumarthi KB, Nakajima H, Rubart M, Soonpaa MH, de la Rivière AB, Doevendans PA, Field LJ. Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction. Cardiovascular Research. 78: 18-25. PMID 18079102 DOI: 10.1093/Cvr/Cvm101  0.381
2008 van Oorschot AA, Sluijter J, Doevendans P, Goumans M. The effect of hypoxia on cardiomyocyte progenitor cell function Journal of Molecular and Cellular Cardiology. 44: 823. DOI: 10.1016/J.YJMCC.2008.02.267  0.376
2007 Goumans MJ, de Boer TP, Smits AM, van Laake LW, van Vliet P, Metz CH, Korfage TH, Kats KP, Hochstenbach R, Pasterkamp G, Verhaar MC, van der Heyden MA, de Kleijn D, Mummery CL, van Veen TA, ... ... Doevendans PA, et al. TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro. Stem Cell Research. 1: 138-49. PMID 19383394 DOI: 10.1016/J.Scr.2008.02.003  0.784
2007 Timmers L, Lim SK, Arslan F, Armstrong JS, Hoefer IE, Doevendans PA, Piek JJ, El Oakley RM, Choo A, Lee CN, Pasterkamp G, de Kleijn DP. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Research. 1: 129-37. PMID 19383393 DOI: 10.1016/J.Scr.2008.02.002  0.394
2007 van Laake LW, Passier R, Monshouwer-Kloots J, Verkleij AJ, Lips DJ, Freund C, den Ouden K, Ward-van Oostwaard D, Korving J, Tertoolen LG, van Echteld CJ, Doevendans PA, Mummery CL. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Research. 1: 9-24. PMID 19383383 DOI: 10.1016/j.scr.2007.06.001  0.34
2007 van Laake LW, Passier R, Monshouwer-Kloots J, Nederhoff MG, Ward-van Oostwaard D, Field LJ, van Echteld CJ, Doevendans PA, Mummery CL. Monitoring of cell therapy and assessment of cardiac function using magnetic resonance imaging in a mouse model of myocardial infarction. Nature Protocols. 2: 2551-67. PMID 17947998 DOI: 10.1038/Nprot.2007.371  0.362
2007 Winter EM, Grauss RW, Hogers B, van Tuyn J, van der Geest R, Lie-Venema H, Steijn RV, Maas S, DeRuiter MC, deVries AA, Steendijk P, Doevendans PA, van der Laarse A, Poelmann RE, Schalij MJ, et al. Preservation of left ventricular function and attenuation of remodeling after transplantation of human epicardium-derived cells into the infarcted mouse heart. Circulation. 116: 917-27. PMID 17684151 DOI: 10.1161/CIRCULATIONAHA.106.668178  0.41
2007 de Boer TP, van Veen TA, Bierhuizen MF, Kok B, Rook MB, Boonen KJ, Vos MA, Doevendans PA, de Bakker JM, van der Heyden MA. Connexin43 repression following epithelium-to-mesenchyme transition in embryonal carcinoma cells requires Snail1 transcription factor. Differentiation; Research in Biological Diversity. 75: 208-18. PMID 17359298 DOI: 10.1111/j.1432-0436.2006.00133.x  0.308
2007 Evans SM, Mummery C, Doevendans PA. Progenitor cells for cardiac repair. Seminars in Cell & Developmental Biology. 18: 153-60. PMID 17321172 DOI: 10.1016/j.semcdb.2006.12.009  0.375
2007 van Vliet P, Sluijter JP, Doevendans PA, Goumans MJ. Isolation and expansion of resident cardiac progenitor cells. Expert Review of Cardiovascular Therapy. 5: 33-43. PMID 17187455 DOI: 10.1586/14779072.5.1.33  0.791
2006 de Jonge N, Goumans MJ, Lips D, Hassink R, Vlug EJ, van der Meel R, Emmerson CD, Nijman J, de Windt L, Doevendans PA. Controlling cardiomyocyte survival. Novartis Foundation Symposium. 274: 41-51; discussion 51. PMID 17019805  0.35
2006 van Laake LW, Hassink R, Doevendans PA, Mummery C. Heart repair and stem cells. The Journal of Physiology. 577: 467-78. PMID 17008381 DOI: 10.1113/jphysiol.2006.115816  0.413
2006 de Boer TP, van Veen TA, Houtman MJ, Jansen JA, van Amersfoorth SC, Doevendans PA, Vos MA, van der Heyden MA. Inhibition of cardiomyocyte automaticity by electrotonic application of inward rectifier current from Kir2.1 expressing cells. Medical & Biological Engineering & Computing. 44: 537-42. PMID 16937189 DOI: 10.1007/s11517-006-0059-8  0.322
2006 van Oort RJ, van Rooij E, Bourajjaj M, Schimmel J, Jansen MA, van der Nagel R, Doevendans PA, Schneider MD, van Echteld CJ, De Windt LJ. MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-induced heart failure. Circulation. 114: 298-308. PMID 16847152 DOI: 10.1161/CIRCULATIONAHA.105.608968  0.31
2006 van Laake L, Passier R, Kloots J, Ward-van Oostwaard D, van den Brink S, Doevendans P, Mummery C. Transplantation of human embryonic stem cell-derived cardiomyocytes in mice Journal of Molecular and Cellular Cardiology. 40: 1005-1006. DOI: 10.1016/j.yjmcc.2006.03.250  0.337
2005 van Empel VP, Bertrand AT, Hofstra L, Crijns HJ, Doevendans PA, De Windt LJ. Myocyte apoptosis in heart failure. Cardiovascular Research. 67: 21-9. PMID 15896727 DOI: 10.1016/j.cardiores.2005.04.012  0.332
2005 Smits AM, van Vliet P, Hassink RJ, Goumans MJ, Doevendans PA. The role of stem cells in cardiac regeneration. Journal of Cellular and Molecular Medicine. 9: 25-36. PMID 15784162 DOI: 10.1111/j.1582-4934.2005.tb00334.x  0.777
2004 Goumans MJ, Doevendans PA, Atsma D, Mummery C. Somatic stem cells and cardiac repair: where is the science? Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation. 12: 531-533. PMID 25696283  0.436
2004 Hassink RJ, Passier R, Goumans MJ, Mummery CL, Doevendans PA. New and viable cells to replace lost and malfunctioning myocardial tissue. Minerva Cardioangiologica. 52: 433-45. PMID 15514577  0.499
2004 Chuva de Sousa Lopes SM, Feijen A, Korving J, Korchynskyi O, Larsson J, Karlsson S, ten Dijke P, Lyons KM, Goldschmeding R, Doevendans P, Mummery CL. Connective tissue growth factor expression and Smad signaling during mouse heart development and myocardial infarction. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 231: 542-50. PMID 15376321 DOI: 10.1002/Dvdy.20162  0.302
2004 Hassink RJ, Goumans MJ, Mummery CL, Doevendans PA. Human stem cells shape the future of cardiac regeneration research. International Journal of Cardiology. 95: S20-2. PMID 15336839 DOI: 10.1016/s0167-5273(04)90006-x  0.436
2004 Zwaginga JJ, Doevendans P. Stem cell-derived angiogenic/vasculogenic cells: possible therapies for tissue repair and tissue engineering. Clinical and Experimental Pharmacology & Physiology. 30: 900-8. PMID 14678256 DOI: 10.1046/j.1440-1681.2003.03931.x  0.412
2003 Hassink RJ, Dowell JD, Brutel de la Rivière A, Doevendans PA, Field LJ. Stem cell therapy for ischemic heart disease. Trends in Molecular Medicine. 9: 436-41. PMID 14557056 DOI: 10.1016/J.Molmed.2003.08.002  0.442
2003 Mummery C, Ward-van Oostwaard D, Doevendans P, Spijker R, van den Brink S, Hassink R, van der Heyden M, Opthof T, Pera M, de la Riviere AB, Passier R, Tertoolen L. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation. 107: 2733-40. PMID 12742992 DOI: 10.1161/01.Cir.0000068356.38592.68  0.518
2003 Lips DJ, deWindt LJ, van Kraaij DJ, Doevendans PA. Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy. European Heart Journal. 24: 883-96. PMID 12714020  0.307
2003 Wehrens XH, Rossenbacker T, Jongbloed RJ, Gewillig M, Heidbüchel H, Doevendans PA, Vos MA, Wellens HJ, Kass RS. A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating. Human Mutation. 21: 552. PMID 12673799 DOI: 10.1002/humu.9136  0.357
2003 Hassink RJ, Brutel de la Rivière A, Mummery CL, Doevendans PA. Transplantation of cells for cardiac repair. Journal of the American College of Cardiology. 41: 711-7. PMID 12628711 DOI: 10.1016/s0735-1097(02)02933-9  0.462
2002 Wehrens XH, Vos MA, Doevendans PA, Wellens HJ. Novel insights in the congenital long QT syndrome. Annals of Internal Medicine. 137: 981-92. PMID 12484714 DOI: 10.7326/0003-4819-137-12-200212170-00012  0.395
2002 Mummery C, Ward D, van den Brink CE, Bird SD, Doevendans PA, Opthof T, Brutel de la Riviere A, Tertoolen L, van der Heyden M, Pera M. Cardiomyocyte differentiation of mouse and human embryonic stem cells. Journal of Anatomy. 200: 233-42. PMID 12033727 DOI: 10.1046/J.1469-7580.2002.00031.X  0.514
2001 Dumont EA, Reutelingsperger CP, Smits JF, Daemen MJ, Doevendans PA, Wellens HJ, Hofstra L. Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart. Nature Medicine. 7: 1352-5. PMID 11726977 DOI: 10.1038/nm1201-1352  0.463
2001 van Eickels M, Grohé C, Cleutjens JP, Janssen BJ, Wellens HJ, Doevendans PA. 17beta-estradiol attenuates the development of pressure-overload hypertrophy. Circulation. 104: 1419-23. PMID 11560859 DOI: 10.1161/hc3601.095577  0.389
2001 Wehrens XH, Doevendans PA, Widdershoven JW, Dassen WR, Prenger K, Wellens HJ, Gorgels AP. Usefulness of sinus tachycardia and ST-segment elevation in V(5) to identify impending left ventricular free wall rupture in inferior wall myocardial infarction. The American Journal of Cardiology. 88: 414-7. PMID 11545766 DOI: 10.1016/s0002-9149(01)01691-5  0.395
2000 Dumont EA, Hofstra L, van Heerde WL, van den Eijnde S, Doevendans PA, DeMuinck E, Daemen MA, Smits JF, Frederik P, Wellens HJ, Daemen MJ, Reutelingsperger CP. Cardiomyocyte death induced by myocardial ischemia and reperfusion: measurement with recombinant human annexin-V in a mouse model. Circulation. 102: 1564-8. PMID 11004148 DOI: 10.1161/01.cir.102.13.1564  0.481
2000 Hofstra L, Liem IH, Dumont EA, Boersma HH, van Heerde WL, Doevendans PA, De Muinck E, Wellens HJ, Kemerink GJ, Reutelingsperger CP, Heidendal GA. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet (London, England). 356: 209-12. PMID 10963199 DOI: 10.1016/s0140-6736(00)02482-x  0.482
2000 Ophuis AJ, Bär FW, Vermeer F, Janssen W, Doevendans PA, Haest RJ, Dassen WR, Wellens HJ. Angiographic assessment of prospectively determined non-invasive reperfusion indices in acute myocardial infarction. Heart (British Cardiac Society). 84: 164-70. PMID 10908252 DOI: 10.1136/heart.84.2.164  0.372
2000 Doevendans PA, Kubalak SW, An RH, Becker DK, Chien KR, Kass RS. Differentiation of cardiomyocytes in floating embryoid bodies is comparable to fetal cardiomyocytes. Journal of Molecular and Cellular Cardiology. 32: 839-51. PMID 10775488 DOI: 10.1006/Jmcc.2000.1128  0.401
2000 Wehrens XH, Doevendans PA, Ophuis TJ, Wellens HJ. A comparison of electrocardiographic changes during reperfusion of acute myocardial infarction by thrombolysis or percutaneous transluminal coronary angioplasty. American Heart Journal. 139: 430-6. PMID 10689257 DOI: 10.1016/s0002-8703(00)90086-3  0.372
1999 Lutgens E, Daemen M, Kockx M, Doevendans P, Hofker M, Havekes L, Wellens H, de Muinck ED. Atherosclerosis in APOE*3-Leiden transgenic mice: from proliferative to atheromatous stage. Circulation. 99: 276-83. PMID 9892595 DOI: 10.1161/01.CIR.99.2.276  0.332
1998 Wellens HJ, Sie HT, Smeets JL, Ramdat Misier AR, Beukema WP, Doevendans PA. Surgical treatment of atrial fibrillation. Journal of Cardiovascular Electrophysiology. 9: S151-4. PMID 9727691  0.346
1996 Doevendans PA, Wellens HJ. Atrial dissection for atrial fibrillation: when, how much and where? Journal of the American College of Cardiology. 28: 991-3. PMID 8837579 DOI: 10.1016/s0735-1097(96)00355-5  0.353
1995 Doevendans PA, Gorgels AP, van der Zee R, Partouns J, Bär FW, Wellens HJ. Electrocardiographic diagnosis of reperfusion during thrombolytic therapy in acute myocardial infarction. The American Journal of Cardiology. 75: 1206-10. PMID 7778540 DOI: 10.1016/s0002-9149(99)80763-2  0.393
Show low-probability matches.